Abstract
Objective
Cardiometabolic disorders contribute to morbidity and mortality in people with severe mental illnesses (SMI), yet lifestyle-intervention efficacy in patients with SMI is unclear. Israel’s unique mental-health rehabilitation hostels (MHRHs) provide housing to subjects with SMI. We tested how multi-component lifestyle intervention affects cardiometabolic risk-factors in at-risk SMI populations residing in MHRHs.
Methods
In a prospective, cluster-randomized, controlled study, six MHRHs, paired by residents’ functioning level, were randomized to lifestyle intervention (nutrition education, physical education), or usual care. Subjects recruited included those with ≥1 of: BMI > 25 kg/m2; plasma triglycerides ≥150 mg/dL; HbA1c ≥ 5.7%; fasting plasma glucose ≥ 100 mg/dL and plasma HDL < 40(men)/ 50(women) mg/dL. Primary outcome was BMI change after 15 months; other outcomes were plasma lipids levels and glycemic control. Low cooperation in one MHRH pair led to their exclusion, the others were assigned to intervention or control.
Results
Eighty residents were enrolled to intervention groups and 74 to control. Compared to baseline, intervention-arm participants experienced improvements in BMI (–0.83 kg/m2 [–1.36, –0.29] 95%CI), triglycerides (–30.60 mg/dL [–49.39, –11.82]95%CI) and LDL (–15.51 mg/dL [–24.53, –6.50]95%CI) (all P ≤ 0.003). BMI improvement correlated with number of dietitian consultations (r = –0.30; P = 0.001). No significant differences were found between treatment arms in BMI (–0.46 kg/m2 [–1.11, 0.18]95%CI;P = 0.189), triglycerides (–24.70 mg/dL [–57.66, 8.25]95%CI), LDL (–9.24 mg/dL [–20.50, 2.03]95%CI), HDL and glycemic control.
Conclusions
Lifestyle intervention significantly improved BMI, LDL and triglycerides compared to baseline in at-risk MHRHs residents with SMI, yet compared to usual care the differences did not reach statistical significance. The association between the number of dietitian’s consultations and BMI improvement suggests that programs should highlight participants’ adherence.
Your institute does not have access to this article
Access options
Subscribe to Journal
Get full journal access for 1 year
$119.00
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.




References
Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16:163–80.
Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the united states. JAMA Psychiatry. 2015;72:1172–81.
Druss BG, Zhao L, Von Esenwein S, Morrato EH, Marcus SC. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care. 2011;49:599–604.
WHO | Excess mortality in persons with severe mental disorders [Internet]. [cited 2020 Apr 12]. Available from: https://www.who.int/mental_health/evidence/excess_mortality_report/en/
Liu NH, Daumit GL, Dua T, Aquila R, Charlson F, Cuijpers P, et al. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry. 2017;16:30–40.
Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378:e34.
Wen CP, Wai JPM, Tsai MK, Yang YC, Cheng TYD, Lee M-C, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet. 2011;378:1244–53.
Lee D-C, Pate RR, Lavie CJ, Sui X, Church TS, Blair SN. Leisure-time running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol. 2014;64:472–81.
American Diabetes Association. 5. Lifestyle Management: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42:S46–S60.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Circulation. 2019;140:e596–e646.
Cabassa LJ, Ezell JM, Lewis-Fernández R. Lifestyle interventions for adults with serious mental illness: a systematic literature review. Psychiatr Serv. 2010;61:774–82.
Teasdale SB, Ward PB, Rosenbaum S, Samaras K, Stubbs B. Solving a weighty problem: systematic review and meta-analysis of nutrition interventions in severe mental illness. Br J Psychiatry. 2017;210:110–8.
Alvarez-Jiménez M, González-Blanch C, Vázquez-Barquero JL, Pérez-Iglesias R, Martínez-García O, Pérez-Pardal T, et al. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial. J Clin Psychiatry. 2006;67:1253–60.
Daumit GL, Dickerson FB, Wang N-Y, Dalcin A, Jerome GJ, Anderson CAM, et al. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med. 2013;368:1594–602.
Goldberg RW, Reeves G, Tapscott S, Medoff D, Dickerson F, Goldberg AP, et al. MOVE!” Outcomes of a weight loss program modified for veterans with serious mental illness. Psychiatr Serv. 2013;64:737–44.
Usher K, Park T, Foster K, Buettner P. A randomized controlled trial undertaken to test a nurse-led weight management and exercise intervention designed for people with serious mental illness who take second generation antipsychotics. J Adv Nurs. 2013;69:1539–48.
Roe D, Hasson-Ohayon I, Lachman M, Kravetz S. Selecting and implementing evidence-based practices in psychiatric rehabilitation services in Israel: a worthy and feasible challenge. Isr J Psychiatry Relat Sci. 2007;44:47–53.
Roe D, Gross R, Kravetz S, Baloush-Kleinman V, Rudnick A. Assessing psychiatric rehabilitation service (PRS) outcomes in Israel: conceptual, professional and social issues. Isr J Psychiatry Relat Sci. 2009;46:103–10.
McPherson P, Krotofil J, Killaspy H. Mental health supported accommodation services: a systematic review of mental health and psychosocial outcomes. BMC Psychiatry. 2018;18:128.
Natan Z, Tsodikov F, Chernyak R, Gimelfarb Y. [Nutritional assessment of inpatients with schizophrenia]. Harefuah. 2014;153:625.
Gal G, Munitz H, Levav I. Health care disparities among persons with comorbid schizophrenia and cardiovascular disease: a case-control epidemiological study. Epidemiol Psychiatr Sci. 2016;25:541–7.
Bonfioli E, Berti L, Goss C, Muraro F, Burti L. Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials. BMC Psychiatry. 2012;12:78.
Stahl SM, Mignon L, Meyer JM. Which comes first: atypical antipsychotic treatment or cardiometabolic risk? Acta Psychiatr Scand. 2009;119:171–9.
Gough SCL, O’Donovan MC. Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? J Psychopharmacol (Oxford). 2005;19:47–55.
Ryan MCM, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry. 2003;160:284–9.
Firth J, Cotter J, Elliott R, French P, Yung AR. A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychol Med. 2015;45:1343–61.
Dale H, Brassington L, King K. The impact of healthy lifestyle interventions on mental health and wellbeing: a systematic review. Mental Health Rev J. 2014;19:1–26.
Ward PB, Firth J, Rosenbaum S, Samaras K, Stubbs B, Curtis J. Lifestyle interventions to reduce premature mortality in schizophrenia. Lancet Psychiatry. 2017;4:e14.
Acknowledgements
This study was funded by the Israeli Otzma Authority in 2015, grant number 3-12181. This paper was presented in part at the annual conference of Otzma Authority for the presentation of studies in diabetes (2018, October), Tel-HaShomer, Israel.
Author information
Authors and Affiliations
Contributions
FT- research concept and proposal, literature search, data collection and preliminary analysis, manuscript preparation. MS- data analysis, literature search, manuscript preparation, figure design. RG- research tools, preliminary data analysis, manuscript preparation. LP- research concept, literature search, data collection and preliminary analysis, manuscript preparation. VBK-literature search. AR- data analysis. IY - data analysis. YG - literature search, data analysis, manuscript preparation. OM- research concept, literature search, data analysis, manuscript review. RE- principal investigator, research concept, literature search, manuscript review. All authors read and approved the final version.
Corresponding author
Ethics declarations
Competing interests
OM declares Advisory Board from Novo Nordisk, Eli Lilly, Sanofi, Merck Sharp & Dohme, Boehringer Ingelheim, Novartis, AstraZeneca, BOL Pharma; Research grant support through Hadassah Hebrew University Hospital from Novo Nordisk, AstraZeneca; Speaker’s Bureau from AstraZeneca, Novo Nordisk, Eli Lilly, Sanofi, Merck Sharp & Dohme, Boehringer Ingelheim, Jansen. All other authors declare no conflict of interest.
Ethics approval and consent to participate
Authors confirm that the submitted study was conducted according to GCP and ICHH. The study was approved by the IRB of the Ministry of Health, Israel.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Tsodikov, F., Schechter, M., Goldsmith, R. et al. The effect of lifestyle intervention on cardiometabolic risk factors in mental health rehabilitation hostel residents at-risk: a cluster-randomized controlled 15-month trial. Int J Obes 46, 926–934 (2022). https://doi.org/10.1038/s41366-022-01063-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41366-022-01063-w